Two researchers have launched a start-up, Minovacca, aiming to commercialize the use of universal milk exomes — natural nanoparticles contained in milk — to deliver therapeutics, gene editing tools and plasmids to targeted locations in the body. 

For their company, Janos Zempleni and Jiantao Guo from the US University of Nebraska-Lincoln draw on bioorthogonal chemistry techniques to achieve target-specific delivery by chemically and genetically engineering the exosomes. 

Leave a Reply

Your email address will not be published. Required fields are marked *

0
    0
    Your Cart
    Your cart is emptyReturn to Shop